BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 16806138)

  • 21. Genetic polymorphisms in LDLR, APOB, PCSK9 and other lipid related genes associated with familial hypercholesterolemia in Malaysia.
    Lye SH; Chahil JK; Bagali P; Alex L; Vadivelu J; Ahmad WA; Chan SP; Thong MK; Zain SM; Mohamed R
    PLoS One; 2013; 8(4):e60729. PubMed ID: 23593297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel mutation in proprotein convertase subtilisin/kexin type 9 gene leads to familial hypercholesterolemia in a Chinese family.
    Lin J; Wang LY; Liu S; Wang XM; Yong Q; Yang Y; DU LP; Pan XD; Wang X; Jiang ZS
    Chin Med J (Engl); 2010 May; 123(9):1133-8. PubMed ID: 20529551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The contribution of PCSK9 levels to the phenotypic severity of familial hypercholesterolemia is independent of LDL receptor genotype.
    Drouin-Chartier JP; Tremblay AJ; Hogue JC; Ooi TC; Lamarche B; Couture P
    Metabolism; 2015 Nov; 64(11):1541-7. PubMed ID: 26371983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening and verifying the mutations in the LDLR and APOB genes in a Chinese family with familial hypercholesterolemia.
    Lv X; Wang C; Liu L; Yin G; Zhang W; Abdu FA; Shi T; Zhang Q; Che W
    Lipids Health Dis; 2023 Oct; 22(1):175. PubMed ID: 37853441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of LDL receptor gene mutations and the R3500Q mutation of the apoB gene on lipoprotein phenotype of familial hypercholesterolemic patients from a South European population.
    Real JT; Chaves FJ; Ejarque I; García-García AB; Valldecabres C; Ascaso JF; Armengod ME; Carmena R
    Eur J Hum Genet; 2003 Dec; 11(12):959-65. PubMed ID: 14508510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutations in the PCSK9 gene in Norwegian subjects with autosomal dominant hypercholesterolemia.
    Leren TP
    Clin Genet; 2004 May; 65(5):419-22. PubMed ID: 15099351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Familial hypercholesterolemia in Tunisia].
    Jelassi A; Jguirim I; Najah M; Maatouk F; Ben Hamda K; Slimane MN
    Pathol Biol (Paris); 2009 Jul; 57(5):444-50. PubMed ID: 19041195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for a third genetic locus causing familial hypercholesterolemia. A non-LDLR, non-APOB kindred.
    Haddad L; Day IN; Hunt S; Williams RR; Humphries SE; Hopkins PN
    J Lipid Res; 1999 Jun; 40(6):1113-22. PubMed ID: 10357843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel type of familial hypercholesterolemia: double heterozygous mutations in LDL receptor and LDL receptor adaptor protein 1 gene.
    Tada H; Kawashiri MA; Ohtani R; Noguchi T; Nakanishi C; Konno T; Hayashi K; Nohara A; Inazu A; Kobayashi J; Mabuchi H; Yamagishi M
    Atherosclerosis; 2011 Dec; 219(2):663-6. PubMed ID: 21872251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-density lipoprotein receptor gene mutation analysis and structure-function correlation in an Omani arab family with familial hypercholesterolemia.
    Al-Rasadi K; Al-Waili K; Al-Zidi WA; Al-Abri AR; Al-Hinai AT; Al-Sabti HA; Al-Tobi S; Al-Zakwani I; Al-Zadjali F; Al-Hashmi K; Banerjee Y
    Angiology; 2014 Nov; 65(10):911-8. PubMed ID: 24249837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipoprotein(a) in Familial Hypercholesterolemia With Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Gain-of-Function Mutations.
    Tada H; Kawashiri MA; Yoshida T; Teramoto R; Nohara A; Konno T; Inazu A; Mabuchi H; Yamagishi M; Hayashi K
    Circ J; 2016; 80(2):512-8. PubMed ID: 26632531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular basis of familial hypercholesterolemia in Brazil: Identification of seven novel LDLR gene mutations.
    Salazar LA; Hirata MH; Cavalli SA; Nakandakare ER; Forti N; Diament J; Giannini SD; Bertolami MC; Hirata RD
    Hum Mutat; 2002 Apr; 19(4):462-3. PubMed ID: 11933210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular genetic epidemiology of homozygous familial hypercholesterolemia in the Hokuriku district of Japan.
    Mabuchi H; Nohara A; Noguchi T; Kobayashi J; Kawashiri MA; Tada H; Nakanishi C; Mori M; Yamagishi M; Inazu A; Koizumi J;
    Atherosclerosis; 2011 Feb; 214(2):404-7. PubMed ID: 21146822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The molecular basis of familial hypercholesterolemia in the Czech Republic: spectrum of LDLR mutations and genotype-phenotype correlations.
    Tichý L; Freiberger T; Zapletalová P; Soška V; Ravčuková B; Fajkusová L
    Atherosclerosis; 2012 Aug; 223(2):401-8. PubMed ID: 22698793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular spectrum of autosomal dominant hypercholesterolemia in France.
    Marduel M; Carrié A; Sassolas A; Devillers M; Carreau V; Di Filippo M; Erlich D; Abifadel M; Marques-Pinheiro A; Munnich A; Junien C; ; Boileau C; Varret M; Rabès JP
    Hum Mutat; 2010 Nov; 31(11):E1811-24. PubMed ID: 20809525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genomic characterization of two deletions in the LDLR gene in Tunisian patients with familial hypercholesterolemia.
    Jelassi A; Slimani A; Rabès JP; Jguirim I; Abifadel M; Boileau C; Najah M; M'rabet S; Mzid J; Slimane MN; Varret M
    Clin Chim Acta; 2012 Dec; 414():146-51. PubMed ID: 22910581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. APOE p.Leu167del mutation in familial hypercholesterolemia.
    Awan Z; Choi HY; Stitziel N; Ruel I; Bamimore MA; Husa R; Gagnon MH; Wang RH; Peloso GM; Hegele RA; Seidah NG; Kathiresan S; Genest J
    Atherosclerosis; 2013 Dec; 231(2):218-22. PubMed ID: 24267230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic analysis of familial hypercholesterolaemia in Western Australia.
    Hooper AJ; Nguyen LT; Burnett JR; Bates TR; Bell DA; Redgrave TG; Watts GF; van Bockxmeer FM
    Atherosclerosis; 2012 Oct; 224(2):430-4. PubMed ID: 22883975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and functional characterization of LDLR mutations in familial hypercholesterolemia patients from Southern Italy.
    Romano M; Di Taranto MD; D'Agostino MN; Marotta G; Gentile M; Abate G; Mirabelli P; Di Noto R; Del Vecchio L; Rubba P; Fortunato G
    Atherosclerosis; 2010 Jun; 210(2):493-6. PubMed ID: 20045108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel functional APOB mutations outside LDL-binding region causing familial hypercholesterolaemia.
    Alves AC; Etxebarria A; Soutar AK; Martin C; Bourbon M
    Hum Mol Genet; 2014 Apr; 23(7):1817-28. PubMed ID: 24234650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.